Afya Announces Changes to Its Board of Directors
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education group in Brazil, announced the resignation of Mrs. Shobhna Mohn from its Board of Directors, effective June 30, 2024. Mohn's departure is unrelated to Afya’s operations or practices. During her tenure, she contributed significantly to Afya's growth, supporting its journey to becoming a top medical education and practice solutions provider in Brazil. Afya highlighted her strategic insights and leadership as pivotal to its success. The company has no immediate plans to fill her position. The board remains committed to strong governance with diverse skills and experience.
- Mrs. Shobhna Mohn's significant contributions supported Afya's growth as a leading medical education group.
- Mohn's leadership and strategic insights were instrumental in Afya's success.
- No immediate plans to appoint a new board member could affect governance continuity.
NOVA
During her tenure as a member of the Board of Directors, Mrs. Mohn has made significant and valuable contributions to the Company, supporting its journey towards becoming
"As CEO, I sincerely thank Mrs. Mohn for her invaluable contributions and solid dedication to our Company. Her strategic insights and leadership have been fundamental in our growth and success. We wish her all the best in her future endeavors and remain grateful for her lasting impact on our organization," said Virgilio Gibbon, Afya’s CEO.
Shobhna Mohn mentioned: “It has been a privilege and an honor to be part of building Afya, working with some of the best investors, board members and management in the industry, seeing it list on Nasdaq in 2019, and becoming an industry reference in a key and impactful sector while spearheading innovation. For me personally, it was a great way to get introduction to the Brazilian Market with exemplary structures when it comes to quality medical education. I wish everyone in the Board and Management continued success and impact and will certainly miss our regular exchanges.”
Afya, also announces that there are no immediate plans for Bertelsmann SE&Co. KGaA to appoint a new member to fill her position on the Board of Directors. Afya remains steadfast in its commitment to maintaining a strong and effective board with the requisite skills and experience to guide the company forward and ensure our continued success.
Afya’s Board of Directors is composed of two co-chairmen - one representing Bertelsmann SE&Co. KGaA, and one representing the Esteves family - two more members of Bertelsmann SE&Co. KGaA, one more member of the Esteves family, one member from Softbank and four independent members, resulting in a diversity of skills and experience to enhance Afya’s decision-making:
BOARD OF DIRECTORS | |
Name | Office |
Nicolau Carvalho Esteves | Co-Chairman of the Board |
Kay Krafft | Co-Chairman of the Board |
Benedikt Dalkmann | Director |
Christina Krebs | Director |
Renato Tavares Esteves | Director |
Maria Tereza Azevedo | Director |
João Paulo Seibel de Faria | Independent Director |
Vanessa Claro Lopes | Independent Director |
Miguel Filisbino Pereira de Paula | Independent Director |
Marcelo Ken Suhara | Independent Director |
About Afya Limited (Nasdaq: AFYA, B3: A2FY34)
Afya is a leading medical education group in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240701202967/en/
Investor Contact: ir@afya.com.br
IR Website: ir.afya.com.br
Media Contact:
Cíntia Moraes Marin
cintia.marin@afya.com.br
Source: Afya Limited
FAQ
When is Mrs. Shobhna Mohn resigning from Afya's Board of Directors?
What is the stock symbol for Afya ?
Why is Mrs. Shobhna Mohn resigning from Afya's Board of Directors?
Will Afya appoint a new member to its Board of Directors after Mrs. Mohn's resignation?